Combined Oral Contraceptives for Heavy Menstrual Bleeding in Anemia

Efficacy of Combined Oral Contraceptives for Heavy Menstrual Bleeding

The American College of Obstetricians and Gynecologists recommends second-line options, such as ethinylestradiol-based COCs with other progestogens, for women who do not tolerate the first-line option, with moderate-quality evidence 1, 2
For women requiring both contraception and treatment of heavy menstrual bleeding, 17β-estradiol-based combined oral contraceptives with either acetate nomegestrol or dienogest are also effective options, according to the Blood Reviews guideline 1, 3

The Centers for Disease Control and Prevention recommends standard administration of COCs, involving 21-24 consecutive days of active pills followed by 4-7 hormone-free days, to reduce menstrual bleeding 2
For women experiencing breakthrough bleeding during COC use, the MMWR Recommendations and Reports guideline suggests short-term treatment options, including NSAIDs for 5-7 days 4, 5

The MMWR Recommendations and Reports guideline recommends assessing blood pressure at follow-up visits for women using COCs, to evaluate the safety of continued use 6
Monitoring hemoglobin levels is also recommended to evaluate improvement in anemia, according to the MMWR Recommendations and Reports guideline 4
Evaluating for any changes in health status that might affect the safety of continued COC use is also recommended, as per the MMWR Recommendations and Reports guideline 6